Ajay Samkaria: The Evolution of Hemostasis Diagnostics with the ACL TOP 70 Series
Ajay Samkaria, Senior Area Sales Manager at Werfen, shared AFMS‘s post on LinkedIn:
“Innovation in Hemostasis.
Excellence in Diagnostics.
The evolution of hemostasis diagnostics is not just about advanced technology; it’s about creating smarter workflows, improving laboratory efficiency, and delivering greater confidence in diagnostic results.
The ACL TOP 70 Series reflects this direction, bringing together automation, standardization, connectivity, and quality management to support the evolving needs of modern laboratories.
At Werfen, innovation is driven by a clear purpose: transforming specialized diagnostics into meaningful value for laboratories, healthcare professionals, and ultimately, patients.
Proud to be part of this journey!”
Abdulla Fouad for Medical Supplies and Services Company (AFMS) shared a post on LinkedIn:
“The New ACL TOP 70 Series is officially launched
We are proud to announce the official launch of the New ACL TOP 70 Series in the Kingdom with our partner Werfen, advancing Hemostasis testing for improved efficiency and standardization.
Main characteristics:
- Elevating standardization across the network, with standardized results and workflows across all systems
- NEW automation and connectivity for greater efficiency
- Broad Hemostasis testing automation, covering routine and specialty testing on one platform
- Centralized quality management, with centralized QC and automated performance verification tools
Fewer steps, more control.
Contributing Towards Better Patient Care and Safety.”

Stay updated with Hemostasis Today.
-
Nov 20, 2026, 17:20Dhinesh Selvaraju: Caplacizumab Becomes the First FDA-Approved Treatment for Pediatric aTTP
-
Nov 20, 2026, 17:19Paris Margaritis: Presenting Preclinical Data on GENV-HEM at the WFH Workshop
-
Nov 20, 2026, 17:18WFH Opens Public Comment on Draft Guidelines for Hemostatic Agents and Prophylaxis
-
Nov 20, 2026, 17:18Ketan Asawale: Consensus on the Management of Cancer-Associated Thrombosis in India
-
Nov 20, 2026, 17:16Raising Awareness of Bleeding Disorders in Women Through the Red Flag Campaign – Perth Blood Institute
-
Nov 20, 2026, 15:11Muhammet Özbilen: Rivaroxaban vs Apixaban – The Menstrual Bleeding Difference
-
Nov 20, 2026, 14:54Fostamatinib in Immune Thrombocytopenia: Targeting Spleen Tyrosine Kinase to Reduce Platelet Destruction
-
Nov 20, 2026, 14:37Giuseppe Leone: The Evolving Treatment Landscape of Adult ITP
-
Nov 20, 2026, 14:25Sameer A.: When Heparin Triggers Thrombosis – A Case of HIT